About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The group of Clinical Neuroimmunology - Centre d'Esclerosi Múltiple de Catalunya (Cemcat) at the Vall d'Hebron Institut de Recerca (VHIR) is a multidisciplinary group dedicated to clinical assistance, physical and cognitive rehabilitation, and clinical and basic research on multiple sclerosis (MS). Cemcat is a national but also an international reference center in the clinical assistance of MS patients. The research performed in the group is divided and further combined in clinical and basic research. In addition, basic research has a marked translational character since the ultimate goal of the group is to improve the quality of life of patients suffering from MS, through in-depth knowledge of the pathogenic mechanisms of the disease and the development of new and more effective therapeutic approaches.
PMID: 38071581 Journal: Journal of NeuroInterventional Surgery Year: 2023 Reference: J Neurointerv Surg. 2023 Dec 7:jnis-2023-021033. doi: 10.1136/jnis-2023-021033. Impact factor: Publication type: Paper in international publication Authors: Aixut, Sonia; Chirife Chaparro, Oscar; de Dios Lascuevas, Marta; Dinia, Lavinia; Gonzalez, Alejandro; Gramegna, Laura Ludovica; Hernandez, David; Luttich, Alex; Moreu, Manuel; Murias, Eduardo et al. DOI: 10.1136/jnis-2023-021033
PMID: 38079177 Journal: JAMA Neurology Year: 2023 Reference: JAMA Neurol. 2023 Dec 11. doi: 10.1001/jamaneurol.2023.4737. Impact factor: Publication type: Paper in international publication Authors: Absinta, Martina; Barakovic, Muhamed; Barkhof, Frederik; Cagol, Alessandro; Calabrese, Massimiliano; Castellaro, Marco; Ciccarelli, Olga; Cocozza, Sirio; Cortese, Rosa; De Stefano, Nicola et al. DOI: 10.1001/jamaneurol.2023.4737
PMID: 38081749 Journal: ANNALS OF NEUROLOGY Year: 2023 Reference: Ann Neurol. 2023 Dec 11. doi: 10.1002/ana.26856. Impact factor: Publication type: Other (letters to the editor, abstracts, corrigendum, etc.) Authors: Alvarez-Fernandez, Antonio; Canete-Ramirez, Carme; Cobo-Calvo, Alvaro; Espejo, Carmen; Fernandez-Polo, Aurora; Gartner, Silvia; Jimenez-Lozano, Ines; Luna-Paredes, Carmen; Monte-Boquet, Emilio; Roch-Santed, Maria et al. DOI: 10.1002/ana.26856
PMID: 38082114 Journal: Behavior Research Methods Year: 2023 Reference: Behav Res Methods. 2023 Dec 11. doi: 10.3758/s13428-023-02303-1. Impact factor: Publication type: Paper in international publication Authors: Aixut, Sonia; Chirife Chaparro, Oscar; de Dios Lascuevas, Marta; Dinia, Lavinia; Gonzalez, Alejandro; Gramegna, Laura Ludovica; Hernandez, David; Luttich, Alex; Manolov, Rumen; Moreu, Manuel et al. DOI: 10.3758/s13428-023-02303-1
PMID: 33870790 Journal: Multiple Sclerosis Journal Year: 2022 Reference: Mult Scler. 2022 Jan;28(1):71-81. doi: 10.1177/13524585211010082. Epub 2021 Apr 19. Impact factor: 6.312 Publication type: Paper in international publication Authors: Pinteac, Rucsanda; Granziera, Cristina; Sastre-Garriga, Jaume; Benkert, Pascal; Auger, Cristina; Kuhle, Jens; Montalban, Xavier; Rovira, Alex; Fissolo, Nicolas; Pareto, Deborah et al. DOI: 10.1177/13524585211010082
PMID: 34716250 Journal: NEUROLOGY Year: 2022 Reference: Neurology. 2022 Jan 4;98(1):e1-e14. doi: 10.1212/WNL.0000000000013016. Epub 2021 Oct 29. Impact factor: 9.91 Publication type: Paper in international publication Authors: Filippi, Massimo; Preziosa, Paolo; Meani, Alessandro; Costa, Gloria Dalla; Mesaros, Sarlota; Drulovic, Jelena; Ivanovic, Jovana; Rovira, Alex; Tintore, Mar; Montalban, Xavier et al. DOI: 10.1212/WNL.0000000000013016
PMID: 34596743 Journal: JOURNAL OF NEUROLOGY Year: 2022 Reference: J Neurol. 2022 Jan;269(1):452-459. doi: 10.1007/s00415-021-10823-z. Epub 2021 Oct 1. Impact factor: 4.849 Publication type: Paper in international publication Authors: Tur, Carmen; Auger, Cristina; Sastre-Garriga, Jaume; Montalban, Xavier; Cobo, Alvaro; Nos, Carlos; Arrambide, Georgina; Castillo, Joaquim; Rio, Jordi; Gasperini, Claudio et al. DOI: 10.1007/s00415-021-10823-z
PMID: 34988947 Journal: ACTA NEUROLOGICA BELGICA Year: 2022 Reference: Acta Neurol Belg. 2022 Jun;122(3):823-825. doi: 10.1007/s13760-021-01864-2. Epub 2022 Jan 6. Impact factor: 2.396 Publication type: Letter or abstract Authors: Lallana, Sofia; Sanchez-Tejerina, Daniel; Auger, Cristina; Callejo, Ana; Rio, Jordi; Cobo-Calvo, Alvaro et al. DOI: 10.1007/s13760-021-01864-2
PMID: 34237417 Journal: AUTOIMMUNITY REVIEWS Year: 2021 Reference: Autoimmun Rev. 2021 Sep;20(9):102893. doi: 10.1016/j.autrev.2021.102893. Epub 2021 Jul 5. Impact factor: 9.754 Publication type: Review in international publication Authors: Dema, Maria, Eixarch, Herena, Villar, Luisa M, Montalban, Xavier, Espejo, Carmen et al. DOI: 10.1016/j.autrev.2021.102893
PMID: 33237430 Journal: NEURORADIOLOGY Year: 2021 Reference: Neuroradiology. 2021 Jul;63(7):1031-1041. doi: 10.1007/s00234-020-02604-8. Epub 2020 Nov 25. Impact factor: 2.804 Publication type: Paper in international publication Authors: Perez-Miralles, Francisco Carlos, Rio, Jordi, Pareto, Deborah, Vidal-Jordana, Angela, Auger, Cristina, Arrambide, Georgina, Castillo, Joaquin, Tintore, Mar, Rovira, Alex, Montalban, Xavier et al. DOI: 10.1007/s00234-020-02604-8
PMID: 34052900 Journal: MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE Year: 2021 Reference: MAGMA. 2021 Dec;34(6):903-914. doi: 10.1007/s10334-021-00933-0. Epub 2021 May 29. Impact factor: 2.31 Publication type: Paper in international publication Authors: Alonso, Juli, Pareto, Deborah, Alberich, Manel, Kober, Tobias, Marechal, Benedicte, Llado, Xavier, Rovira, Alex et al. DOI: 10.1007/s10334-021-00933-0
PMID: 33786942 Journal: EUROPEAN JOURNAL OF NEUROLOGY Year: 2021 Reference: Eur J Neurol. 2021 Aug;28(8):2533-2542. doi: 10.1111/ene.14845. Epub 2021 Apr 19. Impact factor: 6.089 Publication type: Paper in international publication Authors: Rovira, Alex, Tintore, Mar, Sastre-Garriga, Jaume, Tortorella, Carla, Haggiag, Shalom, Galgani, Simonetta, Capra, Ruggero, Pozzilli, Carlo, Montalban, Xavier, Rio, Jordi et al. DOI: 10.1111/ene.14845
PMID: 32877352 Journal: JOURNAL OF MEDICAL INTERNET RESEARCH Year: 2020 Reference: J Med Internet Res. 2020 Sep 25;22(9):e19992. doi: 10.2196/19992. Impact factor: 5.034 Publication type: Paper in international publication Authors: Lamers, Femke, Siddi, Sara, Haro, Josep Maria, Myin-Germeys, Inez, Rintala, Aki, Wykes, Til, Narayan, Vaibhav A, Comi, Giancarlo, Hotopf, Matthew, Dobson, Richard Jb et al. DOI: 10.2196/19992
PMID: 32772807 Journal: Multiple Sclerosis Journal Year: 2020 Reference: Mult Scler. 2020 Sep;26(10):1163-1171. doi: 10.1177/1352458520948231. Epub 2020 Aug 10. Impact factor: 5.412 Publication type: Paper in international publication Authors: Moss, Brandon P, Mahajan, Kedar R, Bermel, Robert A, Hellisz, Kelsey, Hua, Le H, Hudec, Timothy, Husak, Scott, McGinley, Marisa P, Ontaneda, Daniel, Wang, Zhini et al. DOI: 10.1177/1352458520948231
PMID: 31221001 Journal: Multiple Sclerosis Journal Year: 2020 Reference: Mult Scler. 2020 Aug;26(9):1074-1082. doi: 10.1177/1352458519851428. Epub 2019 Jun 21. Impact factor: 5.412 Publication type: Paper in international publication Authors: Peroni, Silvia, Sorosina, Melissa, Malhotra, Sunny, Clarelli, Ferdinando, Osiceanu, Ana Maria, Ferre, Laura, Roostaei, Tina, Rio, Jordi, Midaglia, Luciana, Villar, Luisa Maria et al. DOI: 10.1177/1352458519851428
PMID: 32715174 Journal: Journal of vascular surgery cases and innovative techniques Year: 2020 Reference: J Vasc Surg Cases Innov Tech. 2020 May 11;6(3):374-380. doi: 10.1016/j.jvscit.2020.04.006. eCollection 2020 Sep. Impact factor: 0 Publication type: Paper in international publication Authors: Lopez, Orlando, Pinana, Carlos, Gramegna, Laura Ludovica, Rodriguez, Jose, Hernandez, David, Tomasello, Alejandro et al. DOI: 10.1016/j.jvscit.2020.04.006
PMID: 29234597 Journal: NeuroImage-Clinical Year: 2018 Reference: Neuroimage Clin. 2017 Nov 20;17:607-615. doi: 10.1016/j.nicl.2017.11.015. eCollection 2018. Impact factor: 3.869 Publication type: Paper in international publication Authors: Salem, Mostafa, Cabezas, Mariano, Pareto, Deborah, Oliver, Arnau, Salvi, Joaquim, Rovira, Alex, Llado, Xavier, Valverde, Sergi et al. DOI: 10.1016/j.nicl.2017.11.015
In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.
Dr. Carmen Espejo and Dr. Georgina Arrambide, researchers at Cemcat and Vall d'Hebron Research Institute, are the first authors of the article.
The research findings propose to modify the McDonald 2017 criteria, only in those in whom diagnosis using the current criteria is not possible.
Simoa HD1 equipment
We are looking for 100 healthy volunteers aged 18 or over to participate in a project where the usefulness of biomarkers in serum will be evaluated to predict the prognosis of the disease and the response to treatments.
